Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-11-09 Purchase |
2020-11-12 5:54 pm |
Cerevel Therapeutics Holdings Inc. | CERE | BAIN CAPITAL INVESTORS LLC BC Perception Holdings LP BCPE Perception GP LLC Bain Capital Fund XII LP Bain Capital Partners XII LLC 10% Owner |
332,293 | $10.3 | $3,422,618 | 60,632,356 (Indirect) |
View |
| 2020-11-09 Purchase |
2020-11-12 5:54 pm |
Cerevel Therapeutics Holdings Inc. | CERE | Koppel Adam Director 10% Owner |
332,293 | $10.3 | $3,422,618 | 60,632,356 (Indirect) |
View |
| 2020-11-09 Purchase |
2020-11-12 5:51 pm |
Cerevel Therapeutics Holdings Inc. | CERE | Gordon Christopher R Director 10% Owner |
332,293 | $10.3 | $3,422,618 | 60,632,356 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-06-10 Option Award |
2021-06-14 8:14 pm |
N/A 2031-06-10 |
Cerevel Therapeutics Holdings Inc. | CERE | RIEDEL NORBERT G Director |
58,003 | $0 | 58,003 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-14 8:11 pm |
N/A 2031-06-10 |
Cerevel Therapeutics Holdings Inc. | CERE | Sulzberger Gabrielle Director |
58,003 | $0 | 58,003 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-14 8:09 pm |
N/A 2031-06-10 |
Cerevel Therapeutics Holdings Inc. | CERE | DEKKERS MARIJN E Director |
58,003 | $0 | 58,003 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-14 8:04 pm |
N/A 2031-06-10 |
Cerevel Therapeutics Holdings Inc. | CERE | Giordano Douglas E. Director |
58,003 | $0 | 58,003 (Direct) |
View |
| 2021-06-01 Option Award |
2021-06-03 4:34 pm |
N/A 2031-06-01 |
Cerevel Therapeutics Holdings Inc. | CERE | Akamine Scott Chief Legal Officer |
281,762 | $0 | 281,762 (Direct) |
View |
| 2021-06-01 Option Award |
2021-06-03 4:24 pm |
N/A 2031-06-01 |
Cerevel Therapeutics Holdings Inc. | CERE | Ceesay Abraham President |
461,065 | $0 | 461,065 (Direct) |
View |
| 2021-02-03 Option Award |
2021-02-05 6:56 pm |
N/A 2031-02-03 |
Cerevel Therapeutics Holdings Inc. | CERE | Sanchez Ramiro Chief Medical Officer |
278,637 | $0 | 278,637 (Direct) |
View |
| 2021-02-03 Option Award |
2021-02-05 6:51 pm |
N/A 2031-02-03 |
Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer |
247,678 | $0 | 247,678 (Direct) |
View |
| 2021-02-03 Option Award |
2021-02-05 6:50 pm |
N/A 2031-02-03 |
Cerevel Therapeutics Holdings Inc. | CERE | Tregoning Kathleen See Remarks |
77,399 | $0 | 77,399 (Direct) |
View |
| 2021-02-03 Option Award |
2021-02-05 6:47 pm |
N/A 2031-02-03 |
Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY President and CEO |
732,714 | $0 | 732,714 (Direct) |
View |
| 2021-02-03 Option Award |
2021-02-05 6:46 pm |
N/A 2031-02-03 |
Cerevel Therapeutics Holdings Inc. | CERE | Bodenrader Mark See Remarks |
90,000 | $0 | 90,000 (Direct) |
View |
| 2021-02-03 Option Award |
2021-02-05 6:45 pm |
N/A 2031-02-03 |
Cerevel Therapeutics Holdings Inc. | CERE | DiPietro Kenneth Chief Human Resources Officer |
175,438 | $0 | 175,438 (Direct) |
View |
| 2021-02-03 Option Award |
2021-02-05 6:42 pm |
N/A 2031-02-03 |
Cerevel Therapeutics Holdings Inc. | CERE | Yi Kathy Chief Financial Officer |
216,718 | $0 | 216,718 (Direct) |
View |
| 2021-02-01 Option Award |
2021-02-03 7:28 pm |
N/A 2031-02-01 |
Cerevel Therapeutics Holdings Inc. | CERE | PATRICK DEVAL L Director |
90,390 | $0 | 90,390 (Direct) |
View |
| 2021-02-01 Option Award |
2021-02-03 7:19 pm |
N/A 2031-02-01 |
Cerevel Therapeutics Holdings Inc. | CERE | Baron Deborah Director |
90,390 | $0 | 90,390 (Direct) |
View |
| 2021-01-26 Exercise |
2021-01-28 7:35 pm |
N/A 2029-06-25 |
Cerevel Therapeutics Holdings Inc. | CERE | MISHAN ORLY Chief Business Officer |
38,450 | $0 | 465,363 (Direct) |
View |
| 2021-01-26 Exercise |
2021-01-28 7:35 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | MISHAN ORLY Chief Business Officer |
38,450 | $3.5 | 465,363 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-11 5:06 pm |
N/A 2031-01-04 |
Cerevel Therapeutics Holdings Inc. | CERE | Mckernan Ruth Director |
80,945 | $0 | 80,945 (Direct) |
View |
| 2021-01-04 Exercise |
2021-01-06 4:26 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | RIEDEL NORBERT G Director |
14,270 | $0 | 42,810 (Direct) |
View |
| 2020-12-04 Option Award |
2020-12-08 7:05 pm |
N/A 2030-12-04 |
Cerevel Therapeutics Holdings Inc. | CERE | Tregoning Kathleen See Remarks |
78,229 | $0 | 78,229 (Direct) |
View |
Ownership |
2020-11-02 8:54 pm |
N/A 2029-06-25 |
Cerevel Therapeutics Holdings Inc. | CERE | MISHAN ORLY Chief Business Officer |
0 | $0 | 620,483 (Direct) |
View |
| 2020-10-28 Option Award |
2020-10-30 8:19 pm |
N/A 2030-10-28 |
Cerevel Therapeutics Holdings Inc. | CERE | Yi Kathy Chief Financial Officer |
78,534 | $0 | 78,534 (Direct) |
View |
| 2020-10-28 Option Award |
2020-10-30 8:18 pm |
N/A 2030-10-28 |
Cerevel Therapeutics Holdings Inc. | CERE | Sanchez Ramiro Chief Medical Officer |
130,890 | $0 | 130,890 (Direct) |
View |
| 2020-10-28 Option Award |
2020-10-30 8:14 pm |
N/A 2030-10-28 |
Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer |
117,801 | $0 | 117,801 (Direct) |
View |
| 2020-10-28 Option Award |
2020-10-30 8:13 pm |
N/A 2030-10-28 |
Cerevel Therapeutics Holdings Inc. | CERE | Bodenrader Mark See Remarks |
65,445 | $0 | 65,445 (Direct) |
View |
| 2020-10-28 Option Award |
2020-10-30 8:13 pm |
N/A 2030-10-28 |
Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY President and CEO |
196,335 | $0 | 196,335 (Direct) |
View |
Ownership |
2020-10-30 8:00 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | DEKKERS MARIJN E Director |
0 | $0 | 42,810 (Direct) |
View |
Ownership |
2020-10-30 7:58 pm |
N/A 2029-06-25 |
Cerevel Therapeutics Holdings Inc. | CERE | Yi Kathy Chief Financial Officer |
0 | $0 | 568,776 (Direct) |
View |
Ownership |
2020-10-30 7:57 pm |
N/A 2029-04-02 |
Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer |
0 | $0 | 641,166 (Direct) |
View |
Ownership |
2020-10-30 7:54 pm |
N/A 2030-07-29 |
Cerevel Therapeutics Holdings Inc. | CERE | Tregoning Kathleen See Remarks |
0 | $0 | 344,309 (Direct) |
View |
Ownership |
2020-10-30 7:53 pm |
N/A 2029-02-27 |
Cerevel Therapeutics Holdings Inc. | CERE | Sanchez Ramiro Chief Medical Officer |
0 | $0 | 744,579 (Direct) |
View |